We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

68 hedge funds and large institutions have $270M invested in IVERIC bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,456% more capital invested

Capital invested by funds: $17.3M → $270M (+$252M)

864% more call options, than puts

Call options by funds: $3.64M | Put options by funds: $378K

500% more funds holding in top 10

Funds holding in top 10: 1 → 6 (+5)

182% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 11

42% more funds holding

Funds holding: 48 → 68 (+20)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

Holders
68
Holders Change
+20
Holders Change %
+41.67%
% of All Funds
1.34%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.12%
New
31
Increased
9
Reduced
16
Closed
11
Calls
$3.64M
Puts
$378K
Net Calls
+$3.27M
Net Calls Change
+$3.27M

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$12.2M
2
VMI
VHCP Management III
New York
+$6.07M
3
VMI
VHCP Management II
New York
+$3.59M
4
DM
Deerfield Management
New York
+$3.57M
5
O
OrbiMed
New York
+$3.57M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$2.95M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.25M
3
TA
Tamarack Advisers
California
-$1.25M
4
TCM
Tang Capital Management
California
-$1.25M
5
Renaissance Technologies
Renaissance Technologies
New York
-$493K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
$158K +$65.1K +18,229 +11,914%
AGM
52
Alpine Global Management
New York
$151K +$63K +17,628 New
LC
53
Lindbrook Capital
California
$26K +$10.7K +3,000 New
PAM
54
Panagora Asset Management
Massachusetts
$23K – – –
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$22K -$3.15K -883 -26%
EWM
56
Endurance Wealth Management
Rhode Island
$13K – – –
Citigroup
57
Citigroup
New York
$12K -$925 -259 -15%
Wells Fargo
58
Wells Fargo
California
$7K – – –
AP
59
Atwood & Palmer
Missouri
$6K – – –
Bank of America
60
Bank of America
North Carolina
$5K -$16.9K -4,741 -90%
UBS Group
61
UBS Group
Switzerland
$4K – – –
LTFS
62
Ladenburg Thalmann Financial Services
Florida
$3K – – –
SIS
63
Sound Income Strategies
Florida
$2K – – –
Federated Hermes
64
Federated Hermes
Pennsylvania
$2K +$121 +34 +18%
NC
65
NewSquare Capital
Pennsylvania
$1K – – –
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$352 – – –
Assenagon Asset Management
67
Assenagon Asset Management
Luxembourg
– -$242K -216,036 Closed
Two Sigma Investments
68
Two Sigma Investments
New York
– -$133K -118,306 Closed
BFM
69
Boothbay Fund Management
New York
– -$105K -93,533 Closed
State Street
70
State Street
Massachusetts
– -$47K -41,652 Closed
BIM
71
Bogle Investment Management
Massachusetts
– -$33K -29,067 Closed
SEI Investments
72
SEI Investments
Pennsylvania
– -$31K -28,032 Closed
Deutsche Bank
73
Deutsche Bank
Germany
– -$10K -9,243 Closed
Victory Capital Management
74
Victory Capital Management
Texas
– -$7K -5,960 Closed
CG
75
Cutler Group
California
– -$6.43K -1,800 Closed
1 2
3
4

ISEE Hedge Fund Activity: Q4 2019 in Review

68 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2019, worth a combined $270M — up 1,456% from $17.3M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ISEE positions and 11 closed out — a net gain of 20 holders — while 9 added to existing stakes and 16 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $12.2M. The largest seller was Stonepine Capital Management, cutting an estimated $2.95M.

  • 68 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2019, up from 48 in Q3 2019.
  • Funds reported $270M of IVERIC bio, Inc. Common Stock stock for Q4 2019, up 1,456% quarter-over-quarter.
  • 31 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2019 and 11 closed out, a net change of +20 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q4 2019 was Consonance Capital Management, an estimated $12.2M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q4 2019 was Stonepine Capital Management, an estimated $2.95M sold.

Based on aggregated 13F filings for Q4 2019.